All In Biotech

Drug Trial Radar · NCT02062801

Prophylactic Ephedrine and Combined Spinal Epidurals for Labor

Prophylactic Ephedrine to Reduce Fetal Bradycardia After Combined Spinal Epidural Labor Analgesia: a Randomized Double Blind Placebo-controlled Study

Last checked: Nov 20, 2026Latest source record: Jul 3, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 710 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

710

Actual

Start

Jan 2012

Primary completion

Apr 2013

Study completion Oct 2013

Sponsor

Lead sponsor
Sharp HealthCareAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Feb 14, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Prevention
Who can join
Female only
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The combined spinal epidural (CSE) technique has become increasingly popular for labor pain because of its rapid onset and superior first stage analgesia. However, increased risk for early profound fetal bradycardia (EPFB) following CSE continues to be a concern. Various factors are implicated in the etiology of EPFB but the cause is unknown. Ephedrine administration prior to CSE analgesia may help reduce the risk of EPFB, but to date, nobody has studied the impact of a single dose of intravenous (IV) ephedrine given at the time of CSE administration during labor. The purpose of this study is to measure the incidence of EPFB after combined spinal epidural analgesia using standard definitions. The incidence of EPFB will be compared between patients who receive prophylactic ephedrine or placebo at the time of CSE placement.

Conditions

  • Labor Pain

Interventions

  • EphedrineDrug

    Patients received additional doses of ephedrine 10mg IV to a maximum of 30mg if BP remained low (\<90mmHg systolic) and/was associated with persistent fetal bradycardia or maternal symptoms of dizziness and nausea

  • PlaceboDrug

    Patients received normal saline (placebo) administered immediately after combined spinal epidural (CSE) placement

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Early Profound Fetal BradycardiaTime frame: Within 30 minutes of combined spinal epidural (CSE) placement

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Sharp Mary Birch Hospital for Women and Newborns

    San Diego, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.